WorldQuant Millennium Advisors’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-26,745
Closed -$5.24M 720
2026
Q1
$5.24M Buy
+26,745
New +$5.2M 0.02% 333
2025
Q3
Sell
-1,823
Closed -$327K 538
2025
Q2
$327K Buy
+1,823
New +$317K ﹤0.01% 459
2025
Q1
Sell
-14,444
Closed -$2.18M 440
2024
Q4
$2.18M Sell
14,444
-3,582
-20% -$557K 0.01% 337
2024
Q3
$2.8M Sell
18,026
-60,961
-77% -$9.1M 0.02% 327
2024
Q2
$10.8M Sell
78,987
-41,612
-35% -$5.7M 0.1% 209
2024
Q1
$16.1M Buy
120,599
+116,961
+3,215% +$15.2M 0.2% 148
2023
Q4
$502K Sell
3,638
-8,356
-70% -$1.1M 0.01% 321
2023
Q3
$1.46M Buy
+11,994
New +$1.6M 0.02% 298
2022
Q4
Sell
-26,257
Closed -$3.22M 349
2022
Q3
$3.22M Buy
+26,257
New +$3.46M 0.08% 236
2022
Q2
Sell
-59,140
Closed -$8.09M 306
2022
Q1
$8.09M Buy
+59,140
New +$8.24M 0.2% 165
2021
Q3
Sell
-53,802
Closed -$7.1M 337
2021
Q2
$7.1M Buy
53,802
+41,931
+353% +$5.49M 0.16% 166
2021
Q1
$1.52M Hold
11,871
0.03% 302
2020
Q4
$1.42M Buy
+11,871
New +$1.45M 0.03% 310

Other funds holding DGX

WorldQuant Millennium Advisors's DGX Position: Q2 2026 in Review

WorldQuant Millennium Advisors sold out of Quest Diagnostics (DGX) in Q2 2026, closing a stake of 26,745 shares — an estimated $5.24M sold.

WorldQuant Millennium Advisors first reported a position in DGX in Q4 2020 and held it in 13 quarters. The position peaked at $16.1M in Q1 2024. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • WorldQuant Millennium Advisors reported no remaining Quest Diagnostics position as of Q2 2026 after selling out during the quarter.
  • WorldQuant Millennium Advisors sold 26,745 Quest Diagnostics shares in Q2 2026, an estimated $5.24M.
  • WorldQuant Millennium Advisors first reported a position in Quest Diagnostics in Q4 2020 and held it in 13 quarters.
  • WorldQuant Millennium Advisors's Quest Diagnostics position peaked at $16.1M in Q1 2024.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on WorldQuant Millennium Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.